Jane Street’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Jane Street’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,649	Closed	-$1.59M	–	8487
2020 Q3	$1.59M	Buy	11,649 +1,928	+20%	+$205K	﹤0.01%	3377
2020 Q2	$940K	Buy	9,721 +1,366	+16%	+$114K	﹤0.01%	4153
2020 Q1	$392K	Buy	+8,355	New	+$535K	﹤0.01%	3922
2019 Q4	–	Sell	-5,392	Closed	-$281K	–	6068
2019 Q3	$281K	Buy	+5,392	New	+$287K	﹤0.01%	4249
2019 Q1	–	Sell	-11,943	Closed	-$584K	–	5931
2018 Q4	$584K	Buy	+11,943	New	+$657K	﹤0.01%	3268
2018 Q1	–	Sell	-5,057	Closed	-$213K	–	5678
2017 Q4	$213K	Buy	+5,057	New	+$195K	﹤0.01%	4141

Jane Street's MYOK Position: Q4 2020 in Review

Jane Street sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 11,649 shares — an estimated $1.59M sold.

Jane Street first reported a position in MYOK in Q4 2017 and held it in 6 quarters. The position peaked at $1.59M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Jane Street reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Jane Street sold 11,649 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $1.59M.
Jane Street first reported a position in MyoKardia, Inc. Common Stock in Q4 2017 and held it in 6 quarters.
Jane Street's MyoKardia, Inc. Common Stock position peaked at $1.59M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Jane Street's 13F filing for Q4 2020, filed 17 Feb 2021.